Any old iron?

Brain

Volumn 134, Issue 4, 2011, Pages 924-927

  Morris, Christopher M ^a,b,c  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; HEMOGLOBIN; IRON; IRON REGULATORY PROTEIN 2; MONOAMINE OXYGENASE; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 2; PANTOTHENATE KINASE 2; TAU PROTEIN; TRANSFERRIN; TRYPTOPHAN; TYROSINE 3 MONOOXYGENASE; UBIQUITIN; UNCLASSIFIED DRUG;

ASTROCYTE; ATTENTION; ATTENTION DISTURBANCE; BASAL GANGLION; BLOOD BRAIN BARRIER; BRAIN FUNCTION; CELL DIVISION; CEREBROSPINAL FLUID ANALYSIS; CHOROID PLEXUS; COGNITION; GENE MUTATION; GLOBUS PALLIDUS; HEMOCHROMATOSIS; HUMAN; IRON DEFICIENCY ANEMIA; IRON METABOLISM; IRON TRANSPORT; MEMORY DISORDER; MICROGLIA; MOTIVATION; NERVE CELL; NERVE DEGENERATION; NEUROPATHOLOGY; NEUROTRANSMISSION; NONHUMAN; NOTE; OLIGODENDROGLIA; OXYGEN TRANSPORT; PANTOTHENATE KINASE ASSOCIATED NEURODEGENERATION; PRIORITY JOURNAL; RESTLESS LEGS SYNDROME; SUBSTANTIA NIGRA PARS RETICULATA;

EID: 79953644851     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awr056     Document Type: Note

References (56)

1. Ahl F. Aeneid: Virgil. Oxford: Oxford University Press; 2007.
2. Boserup MW, Lichota J, Haile D, Moos T. Heterogenous distribution of ferroportin-containing neurons in mouse brain. Biometals 2011.
3. Cammermyer J. Deposition of iron in paraventricular areas of the human brain in hemochromatosis. J Neuropathol Exp Neurol 1947; 6: 111-27.
4. Clardy SL, Earley CJ, Allen RP, Beard JL, Connor JR. Ferritin subunits in CSF are decreased in restless legs syndrome. J Lab Clin Med 2006; 147: 67-73. (Pubitemid 43188998)
5. Collard KJ. Iron homeostasis in the neonate. Pediatrics 2009; 123: 1208-16.
6. Connor J. Profile of altered iron aquisition in restless legs syndrome. Brain 2011.
7. Crichton RR, Wilmet S, Legssyer R, Ward RJ. Molecular and cellular mechanisms of iron homeostasis and toxicity in mammalian cells. J Inorg Biochem 2002; 91: 9-18. (Pubitemid 34727756)
8. Crowe A, Morgan EH. Iron and transferrin uptake by brain and cerebro-spinal fluid in the rat. Brain Res 1992; 592: 8-16.
9. Curtis AR, Fey C, Morris CM, Bindoff LA, Ince PG, Chinnery PF, et al. Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. Nat Genet 2001; 28: 350-4. (Pubitemid 32702424)
10. Donovan A, Lima CA, Pinkus JL, Pinkus GS, Zon LI, Robine S, et al. The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. Cell Metab 2005; 1: 191-200. (Pubitemid 43960600)
11. Earley CJ, Connor JR, Beard JL, Malecki EA, Epstein DK, Allen RP. Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome. Neurology 2000; 54: 1698-700. (Pubitemid 30226823)
12. Edvardson S, Hama H, Shaag A, Gomori JM, Berger I, Soffer D, et al. Mutations in the fatty acid 2-hydroxylase gene are associated with leukodystrophy with spastic paraparesis and dystonia. Am J Hum Genet 2008; 83: 643-8.
13. Falkingham M, Abdelhamid A, Curtis P, Fairweather-Tait S, Dye L, Hooper L. The effects of oral iron supplementation on cognition in older children and adults: a systematic review and meta-analysis. Nutr J 2010; 9: 4.
14. Gocht A, Keith AB, Candy JM, Morris CM. Iron uptake in the brain of the myelin-deficient rat. Neurosci Lett 1993; 154: 187-90. (Pubitemid 23172353)
15. Gregory A, Hayflick SJ. Genetics of neurodegeneration with brain iron accumulation. Curr Neurol Neurosci Rep 2011.
16. Hallgren B, Sourander P. The effect of age on the non-haemin iron in the human brain. J Neurochem 1958; 3: 41-51.
17. Hulet SW, Hess EJ, Debinski W, Arosio P, Bruce K, Powers S, et al. Characterization and distribution of ferritin binding sites in the adult mouse brain. J Neurochem 1999; 72: 868-74. (Pubitemid 29055254)
18. Kann O, Huchzermeyer C, Kovacs R, Wirtz S, Schuelke M. Gamma oscillations in the hippocampus require high complex I gene expression and strong functional performance of mitochondria. Brain 2011; 134: 345-58.
19. Kemlink D, Polo O, Frauscher B, Gschliesser V, Hogl B, Poewe W, et al. Replication of restless legs syndrome loci in three European populations. J Med Genet 2009; 46: 315-18.
20. Khateeb S, Flusser H, Ofir R, Shelef I, Narkis G, Vardi G, et al. PLA2G6 mutation underlies infantile neuroaxonal dystrophy. Am J Hum Genet 2006; 79: 942-8. (Pubitemid 44763408)
21. Koeppen AH. The history of iron in the brain. J Neurol Sci 1995; 134 (Suppl): 1-9.
22. Kruer M, Hiken M, Gregory A, Malandrini A, Clark D, Hogarth P, et al. Novel histopathologic findings in molecularly confirmed pantothenate kinase-associated neurodegeneration. Brain 2011.
23. Kruer MC, Paisan-Ruiz C, Boddaert N, Yoon MY, Hama H, Gregory A, et al. Defective FA2H leads to a novel form of neurodegeneration with brain iron accumulation (NBIA). Ann Neurol 2010; 68: 611-18.
24. Kurian MA, Morgan NV, MacPherson L, Foster K, Peake D, Gupta R, et al. Phenotypic spectrum of neurodegeneration associated with mutations in the PLA2G6 gene (PLAN). Neurology 2008; 70: 1623-9. (Pubitemid 351620319)
25. LaVaute T, Smith S, Cooperman S, Iwai K, Land W, Meyron-Holtz E, et al. Targeted deletion of the gene encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice. Nat Genet 2001; 27: 209-14. (Pubitemid 32157451)
26. Li GJ, Zhao Q, Zheng W. Alteration at translational but not transcrip-tional level of transferrin receptor expression following manganese exposure at the blood-CSF barrier in vitro. Toxicol Appl Pharmacol 2005; 205: 188-200. (Pubitemid 40704653)
27. Mash DC, Pablo J, Flynn DD, Efange SM, Weiner WJ. Characterization and distribution of transferrin receptors in the rat brain. J Neurochem 1990; 55: 1972-9. (Pubitemid 120021828)
28. Meyron-Holtz EG, Ghosh MC, Iwai K, LaVaute T, Brazzolotto X, Berger UV, et al. Genetic ablations of iron regulatory proteins 1 and 2 reveal why iron regulatory protein 2 dominates iron homeostasis. EMBO J 2004; 23: 386-95. (Pubitemid 38294503)
29. Mizuno S, Mihara T, Miyaoka T, Inagaki T, Horiguchi J. CSF iron, ferritin and transferrin levels in restless legs syndrome. J Sleep Res 2005; 14: 43-7. (Pubitemid 40396070)
30. Moos T, Morgan EH. The significance of the mutated divalent metal transporter (DMT1) on iron transport into the Belgrade rat brain. J Neurochem 2004; 88: 233-45. (Pubitemid 38030226)
31. Moos T, Rosengren Nielsen T, Skjorringe T, Morgan EH. Iron trafficking inside the brain. J Neurochem 2007; 103: 1730-40. (Pubitemid 350126643)
32. Moos T, Skjoerringe T, Gosk S, Morgan EH. Brain capillary endothelial cells mediate iron transport into the brain by segregating iron from transferrin without the involvement of divalent metal transporter 1. J Neurochem 2006; 98: 1946-58. (Pubitemid 44298257)
33. Morgan NV, Westaway SK, Morton JE, Gregory A, Gissen P, Sonek S, et al. PLA2G6, encoding a phospholipase A2, is mutated in neuro-degenerative disorders with high brain iron. Nat Genet 2006; 38: 752-4. (Pubitemid 43980594)
34. Morris CM, Candy JM, Bloxham CA, Edwardson JA. Distribution of transferrin receptors in relation to cytochrome oxidase activity in the human spinal cord, lower brainstem and cerebellum. J Neurol Sci 1992a; 111: 158-72.
35. Morris CM, Candy JM, Keith AB, Oakley AE, Taylor GA, Pullen RG, et al. Brain iron homeostasis. J Inorg Biochem 1992b; 47: 257-65.
36. Morris CM, Candy JM, Oakley AE, Bloxham CA, Edwardson JA. Histochemical distribution of non-haem iron in the human brain. Acta Anat 1992c; 144: 235-57.
37. Morris CM, Keith AB, Edwardson JA, Pullen RG. Uptake and distribution of iron and transferrin in the adult rat brain. J Neurochem 1992d; 59: 300-6.
38. Paisan-Ruiz C, Bhatia KP, Li A, Hernandez D, Davis M, Wood NW, et al. Characterization of PLA2G6 as a locus for dystonia-parkinsonism. Ann Neurol 2009; 65: 19-23.
39. Rouault TA, Cooperman S. Brain iron metabolism. Semin Pediatr Neurol 2006; 13: 142-8. (Pubitemid 44709651)
40. Rouault TA, Zhang DL, Jeong SY. Brain iron homeostasis, the choroid plexus, and localization of iron transport proteins. Metab Brain Dis 2009; 24: 673-84.
41. Salahudeen AA, Thompson JW, Ruiz JC, Ma HW, Kinch LN, Li Q, et al. An E3 ligase possessing an iron-responsive hemerythrin domain is a regulator of iron homeostasis. Science 2009; 326: 722-6.
42. Stefansson H, Rye DB, Hicks A, Petursson H, Ingason A, Thorgeirsson TE, et al. A genetic risk factor for periodic limb movements in sleep. N Engl J Med 2007; 357: 639-47. (Pubitemid 47267233)
43. Strassmann G. Hemosiderin and tissue iron in the brain, its relationship, occurrence and importance; a study on 93 human brains. J Neuropathol Exp Neurol 1945; 4: 393-401.
44. Taylor EM, Crowe A, Morgan EH. Transferrin and iron uptake by the brain: effects of altered iron status. J Neurochem 1991; 57: 1584-92. (Pubitemid 21922793)
45. Taylor EM, Morgan EH. Role of transferrin in iron uptake by the brain: a comparative study. J Comp Physiol B 1991; 161: 521-4.
46. Todorich B, Zhang X, Slagle-Webb B, Seaman WE, Connor JR. Tim-2 is the receptor for H-ferritin on oligodendrocytes. J Neurochem 2008; 107: 1495-505.
47. Tonelli A, Romaniello R, Grasso R, Cavallini A, Righini A, Bresolin N, et al. Novel splice-site mutations and a large intragenic deletion in PLA2G6 associated with a severe and rapidly progressive form of infantile neuroaxonal dystrophy. Clin Genet 2010; 78: 432-40.
48. Trenkwalder C, Hogl B, Winkelmann J. Recent advances in the diagnosis, genetics and treatment of restless legs syndrome. J Neurol 2009; 256: 539-53.
49. Trenkwalder C, Paulus W. Restless legs syndrome: pathophysiology, clinical presentation and management. Nat Rev Neurol 2010; 6: 337-46.
50. Vashisht AA, Zumbrennen KB, Huang X, Powers DN, Durazo A, Sun D, et al. Control of iron homeostasis by an iron-regulated ubiquitin ligase. Science 2009; 326: 718-21.
51. Vilarino-Guell C, Chai H, Keeling BH, Young JE, Rajput A, Lynch T, et al. MEIS1 p.R272H in familial restless legs syndrome. Neurology 2009; 73: 243-5.
52. Virgil. The Aeneid. In: Ahl F, editor. Vol Book VIII. Oxford: Oxford University Press; 2007.
53. Winkelmann J, Schormair B, Lichtner P, Ripke S, Xiong L, Jalilzadeh S, et al. Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions. Nat Genet 2007; 39: 1000-6. (Pubitemid 47185185)
54. World Health Organization, UNU, UNICEF. Iron deficiency anaemia. Assessment, prevention and control. Vol. Geneva: World Health Organisation; 2001. p. 132.
55. Yoshino H, Tomiyama H, Tachibana N, Ogaki K, Li Y, Funayama M, et al. Phenotypic spectrum of patients with PLA2G6 mutation and PARK14-linked parkinsonism. Neurology 2010; 75: 1356-61.
56. Youdim MB, Yehuda S. The neurochemical basis of cognitive deficits induced by brain iron deficiency: involvement of dopamine-opiate system. Cell Mol Biol 2000; 46: 491-500.